Personalis Secures $50M from Merck, Extends Collaboration with Moderna
What You Should Know:
– Personalis, Inc. (NASDAQ: PSNL) today announced agreements with long-time collaborators Merck and Moderna that accelerate the advancement of the company’s business strategy.
– The company has received a $50M investment from…
Continue Reading